ALT5 Sigma (ALTS)
Blockchain payments and trading infrastructure for enterprise digital asset activity.
Something off on this page? Send us feedback.
ALT5 Sigma provides digital asset payment, trading and settlement infrastructure through ALT5 Pay, ALT5 Prime and StrataCarte. Its business serves institutions and merchants, while a WLFI token treasury and legacy biotech assets add separate structural exposures.
ALT5 Sigma is a fintech company built around digital asset infrastructure rather than consumer crypto apps. Its Fintech & Payments operations center on ALT5 Pay for merchant and platform payment acceptance, ALT5 Prime for over-the-counter digital asset trading, and StrataCarte for multi-currency card programs tied to Visa and Mastercard networks.
The company markets these tools to banks, broker-dealers, funds, family offices, trading firms, payment service providers and merchants, earning through setup, maintenance, spread and transaction fees. It also maintains a WLFI token treasury and retains Alyea Therapeutics, a legacy clinical-stage biotech business that the company has discussed separating. The operating model depends on regulated access to digital assets, reliable banking and custody partners, and controls for KYC, transaction monitoring and anti-money laundering compliance.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $15.5M · Total debt $28.5M · Total assets $959.7M · Shareholders' equity $889.7M
- Revenue
- $4.7M
- Operating income
- −$2.7M
- Net income
- −$271.5M
HistoryDividend
| Institutions | 28.80% | 40.28M shares | |
|---|---|---|---|
| 82 holders · as of Jun 30, 2026 | |||
| Insiders | 0.04% | 58.0K shares | |
| 2 holders · as of Oct 9, 2025 | |||
| Other | 71.16% | 99.50M shares | |
| remainder | |||
139.84M company shares as of Aug 5, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
CRCM LPInstitution | 9.08% | 12.70M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 4.40% | 6.16M | as of Jun 30, 2026 |
Diametric Capital, LPInstitution | 3.86% | 5.39M | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 1.78% | 2.49M | as of Jun 30, 2026 |
UBS Group AGInstitution | 1.62% | 2.27M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 14, 2025 | David C. Danziger | director | +10,000 | $7.30 |
Not reported.